Subscribe To
Infi important deadline: rosen, a global and leading law firm, encourages infinity pharmaceuticals, inc. investors with losses to secure counsel before important october 16 deadline in securities clas
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity
October 8, 2023, 6:08 pm
Shareholder investigation: halper sadeh llc investigates icpt, fncb, pfis
NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
October 8, 2023, 2:25 pm
Ani pharmaceuticals (anip) stock sinks as market gains: here's why
The latest trading day saw ANI pharmaceuticals (ANIP) settling at $58.39, representing a -0.41% change ...
October 6, 2023, 7:32 pm
Defence to present three of its leading products at the upcoming festival of biologics in basel, switzerland
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the ...
October 6, 2023, 6:00 pm
Inozyme pharma announces three poster presentations at the american society for bone and mineral research (asbmr) 2023 annual meeting
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease bio...
October 6, 2023, 12:30 pm
Presidio property trust announces closing of merger of its sponsored spac murphy canyon acquisition corp now trading as conduit pharmaceuticals (nasdaq: cdt and cdttw)
Presidio’s sponsored SPAC completed its previously announced business combination with Conduit pharmaceutica...
October 6, 2023, 12:30 pm
Ocuphire pharma to present at euretina and retina society conferences in october
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE NEWSWIRE) �...
October 6, 2023, 12:00 pm
Is collegium pharmaceutical (coll) a great value stock right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 6, 2023, 11:17 am
Pharma stock upgraded on eye disorder drug sales
Apellis pharmaceuticals Inc (NASDAQ:APLS) stock is enjoying a boost today after an upgrade from J.P....
October 6, 2023, 11:01 am
4 stocks that exhibit solid earnings acceleration
Invest in stocks like Catalyst pharmaceuticals (CPRX), ImmunoGen (IMGN), Inari Medical (NARI) and Kyndr...
October 6, 2023, 9:01 am
Why is rvl pharmaceuticals (rvlp) stock up 28% today?
RVL pharmaceuticals (NASDAQ: RVLP ) stock is climbing higher on Friday despite a lack of news from the...
October 6, 2023, 8:17 am
Infinity pharmaceuticals, inc. investors: lead plaintiff deadline is approaching in the class action against infinity pharmaceuticals, inc.; contact robbins llp today
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities ...
October 5, 2023, 7:18 pm
Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of ars pharmaceuticals, inc. (spry)
NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of ARS ...
October 5, 2023, 4:08 pm
Chugai pharmaceutical co., ltd. unsponsored adr (chgcy) upgraded to buy: here's what you should know
Chugai pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) has been upgraded to a Zacks Rank #2 (Buy), ref...
October 5, 2023, 1:32 pm
Following up on phathom pharmaceuticals
Phathom pharmaceuticals is a small biopharma firm focused on developing treatments for gastrointestinal...
October 5, 2023, 12:43 pm
Novo nordisk's wegovy and ozempic us patents to be examined by appeal board
One of Novo Nordisk's (NYSE:NVO) US patents for its blockbuster weight-loss drugs Ozempic and Wegovy will be reviewed by the US Patent Office afte...
October 5, 2023, 10:44 am
Orchard therapeutics is being bought at a massive premium
Shares of Orchard Therapeutics (NASDAQ: ORTX) almost doubled this morning after Kyowa Kirin Co Ltd (TYO: 4151) announced plans of buying the gene ther...
October 5, 2023, 10:38 am
Orchard therapeutics shares double following japanese bid approach
Shares of Orchard Therapeutics doubled in pre-market trading following the announcement that Japan-based pharm...
October 5, 2023, 8:22 am
Nrx pharmaceuticals to present at 8th annual dawson james conference
RADNOR, Pa. , Oct. 5, 2023 /PRNewswire/ -- NRx pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx ...
October 5, 2023, 6:48 am
Oculis to present a late-breaking abstract at the 23rd euretina congress on positive phase 3 stage 1 diamond trial results for diabetic macular edema
ZUG, Switzerland, and BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis” or the “Company”), a global bio...
October 5, 2023, 6:30 am